T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: Response to cyclosporin A and mycophenolate mofetil [6]

American Journal of Hematology

Volumn 78, Issue 2, 2005, Pages 161-163

  Arcasoy, Murat O ^a   Chao, Nelson J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB;

ADULT; ANEMIA; CASE REPORT; CHROMOSOME ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; AUTOIMMUNITY; CYCLOSPORINE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOPHENOLIC ACID; RED-CELL APLASIA, PURE; T-LYMPHOCYTES;

EID: 13244278102     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20237     Document Type: Letter

References (5)

1. Bailey FA, Lilly M, Bertoli LF, Ball GV. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum 1989;32:901-905.
2. Linardaki GD, Boki KA, Fertakis A, Tzioufas AG. Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin. Scand J Rheumatol 1999;28:189-191.
3. Kiely PD, McGuckin CP, Collins DA, Bevan DH, Marsh JC. Erythrocyte aplasia and systemic lupus erythematosus. Lupus 1995;4:407-411.
4. Duarte-Salazar C, Cazarin-Barrientos J, Goycochea-Robles MV, Collazo-Jaloma J, Burgos-Vargas R. Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology (Oxford) 2000;39:1155-1157.
5. Atzeni F, Sarzi-Puttini P, Capsoni F, Vulpio L, Carrabba M. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. Clin Exp Rheumatol 2003;21:759-762.